ARHGEF3 and neoplasm: The results demonstrated that knockdown of ARHGEF3 led to slower tumor growth (Fig. 1J) and significantly reduced tumor volume (Fig. 1K) and tumor weight (Fig. 1L), and the cells with ARHGEF3 knockdown even could not form obvious xenografts in some models.